Fig. 1From: Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking studyScheme representation of altered-repertoire binding and signaling mechanism of antigen/drug, HLA-receptor, and peptide for T-cell activationBack to article page